OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting

Contributed by: GlobeNewswire

Tags

Organ Transplant

More Like This

OrganOx Opens State-of-the-Art Research, Development, and Production Headquarters in Oxford, UK

OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector

OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

OrganOx Announces Appointment of Naoya Iwata as CEO & President

OrganOx achieves one of the UK's largest medtech exit to date, generating record returns for BGF

Appointment of Stephen M. Deitsch as new Chief Financial Officer